Uproar erupts over zMapp; WHO to convene ethics panel
This article was originally published in Scrip
Executive Summary
An uproar has erupted over questions about why two American aid workers infected with Ebola were the first to receive an experimental drug, which has seemingly had positive results, although it's unclear whether the medicine, which has yet to undergo clinical testing, did indeed lead to their improved conditions.